MyDacla - Daclatasvir Dihydrochloride 60mg Tablet

Daclatasvir Dihydrochloride is a direct-acting antiviral medicine used as part of combination treatment for chronic hepatitis C virus (HCV) infection. It works by targeting the HCV NS5A protein, an important component involved in viral replication and assembly. By interfering with these processes, daclatasvir supports reduction of viral activity and contributes to effective HCV treatment. Its oral formulation provides a convenient option for incorporation into prescribed antiviral regimens. Daclatasvir is selected as part of individualized treatment plans based on the HCV genotype, other medicines used, and the patient’s clinical requirements.